The supermarket ‘antidepressant' in your spice rack
'However, St John's Wort and saffron more often showed effects compared to placebo, and similar results to prescription antidepressants,' Frost wrote in an accompanying editorial in Frontiers of Pharmacology.
Frost, we should note, is a herbal medicine practitioner herself; the first of many caveats we'll cover on this study.
It's not surprising St John's Wort showed a strong effect. A Cochrane review, the gold-standard for scientific evidence, found the flower extract could treat symptoms of depression as effectively as antidepressants back in 2008.
Ian Hickie, professor of psychiatry and co-director of health and policy at the University of Sydney's Brain and Mind Centre, said St John's Wort is known to be pharmacologically similar to a weak SSRI (selective serotonin reuptake inhibitor) antidepressant medication. 'It should be seen as a 'medicine' and not simply a natural product,' he says.
Hickie noted that many of the other natural interventions weighed up in the review were tested on subclinical depression, not the severe illness conventional antidepressants are aimed at, which is important to consider when interpreting the results.
The review also didn't analyse the statistical power of each trial's results, which most modern meta-analyses do, and instead simply collated the number of positive and negative experiments on each substance.
That doesn't take us far, particularly because most of the trials included in the review had small sample sizes.
So where does that leave us with the claim that saffron, alongside St John's Wort, could be as potent as a prescription antidepressant?
A narrow evidence base
Eighteen studies on saffron were included in the review. Most found the substance improved people's mood and alleviated depression at least as well as conventional medication.
But, reading the studies one by one, something caught my eye: at least half were co-authored by the same researcher.
Further, all but one of the studies emerged from a small group of research organisations in Iran. That's not surprising; Iran produces 90 per cent of the world's saffron, so naturally the country's scientists would lead experiments on its therapeutic potential.
What it does show, however, is that the experimental landscape for saffron is very concentrated. To be confident that a certain new drug or intervention works, ideally, you want labs across many countries running experiments with a range of settings and participants of different ethnicities.
It's safe to say the evidence base, as it stands, is narrow.
The one study referenced in the paper completed outside of Iran was an Australian one led by Dr Adrian Lopresti, which found saffron extract could help reduce depressive symptoms in people already taking a pharmaceutical antidepressant.
Lopresti, who's the managing director of Clinical Trials Australia, also just published a new paper that marks the largest study to date on saffron and mood, with 202 participants.
The trial found 72.3 per cent of participants with depressive symptoms (not clinical depression) taking saffron extract significantly improved compared to 54.3 per cent of people on a placebo.
Scientists believe saffron could address chemical issues associated with depression, which include problems with neurotransmitters, high inflammatory blood markers, and low levels of antioxidants.
'Saffron is an anti-inflammatory, it's an antioxidant, and it impacts on neurotransmitters too, so it probably works through those different mechanisms,' Lopresti says.
Fine print and industry funding
But these Australian studies, too, come with a crucial caveat: they were funded by a biotech company that sells saffron supplements.
'I think what you've got to really do is not hedge your bets on just one single study,' Lopresti says when I ask how people should interpret studies funded by industry. 'Has it been replicated across the world with different research organisations?'
Loading
Jerome Sarris, professor of integrative mental health at the NICM medical research institute, said it's important to note potential conflicts of interest. But they can be managed in placebo-controlled, double-blind studies – where participants and experimenters don't know who's on the placebo – as long as data is analysed independently of industry.
'Of course, read the fine print, look at the conflict of interest and weigh that up in your own mind. But I would also say universities are pretty good in terms of having safeguards around conflict of interest management,' he says.
People considering supplements for mood or mental illness should seek professional health advice. Herbs and other supplements can interact with other medications. St John's Wort, for example, can lead to a potentially life-threatening increase in serotonin when combined with some antidepressants.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Perth Now
9 hours ago
- Perth Now
Australian-made green plane fuel closer with grant win
Forget farm waste: Australian researchers are developing a way to make environmentally friendly aviation fuel using renewable energy, water and carbon dioxide. The innovative project, undertaken at the University of NSW, has won a $1.2 million grant to progress the technology and scientists say a prototype could be as little as six months from launch. The announcement on Thursday comes amid increasing demand for sustainable aviation fuel in Australia and worldwide and follows the launch of several multimillion-dollar projects designed to turn waste into jet fuel. Sustainable aviation fuel, or SAF, is typically made from agricultural waste such as sugarcane, tallow, canola and cooking oils and can reduce emissions from aircraft by 80 per cent compared to traditional jet fuel. But the UNSW project deploys an electrolyser that uses low-cost metals, carbon catalysts and renewable energy to turn carbon dioxide and water into fuel precursors. The approach could cut out the need for farm waste and make environmentally friendly fuel easier to produce at scale, project leader Rahman Daiyan said. "Most of the work so far has been on bio-based sustainable aviation fuel projects," he told AAP. "But those sort of biomass resources are limited to some extent." The Trailblazer for Recycling and Clean Energy program, established by the federal education department, has awarded the UNSW research team an additional $1.2 million to scale up its technology. While the electrolyser has been proven to work in a lab, Dr Daiyan said a validated prototype would be ready within six to nine months, and the project would be commercialised with industry partners Tjindu Power and Chinese energy firm Chuangqi Times. If successful, he said, the project could help to realise Australian ambitions to become a green fuel exporter. "One of the best aspects of this technology is that it allows us to leverage Australia's potential – we want to be a hydrogen exporter or a low-carbon fuel exporter," Dr Daiyan said. "There is domestic demand but there is also overseas demand because apart from Singapore and Malaysia there are not a lot of places to make SAF for the Asia Pacific region." Sustainable aviation fuel is considered to be one of the leading ways to reduce carbon emission from air travel and is in high demand worldwide after major airlines committed to using the fuel to achieve net-zero emissions by 2050. A report by the CSIRO and aircraft maker Boeing, released in November, found Australia could lead the world in production of the sustainable fuel but warned it had made only moderate progress so far. Sustainable aviation fuel projects are under way in Queensland and Western Australia, including a refinery planned by Wagner Sustainable Fuels and plans to transform BP's Kwinana Energy Hub in Western Australia.


West Australian
10 hours ago
- West Australian
Private healthcare giant Ramsay shuts psychology clinics
The country's biggest private hospital company will shut the majority of its psychology clinics in a matter of months. Ramsay Health Care notified staff of the closure of 17 of its 20 clinics earlier this month. The three remaining clinics are in the Newcastle suburb of Charlestown, in Perth's northern suburbs, and in Cairns. 'We understand this change might be unsettling and we are working closely with our psychologists to ensure every client is supported and has continuity of care, whether through our existing and expanded Telehealth service or with another trusted provider, depending on what is clinically appropriate,' a spokesperson said. 'This change is part of Ramsay's broader strategy to strengthen how we deliver high-quality, accessible and connected care across hospital, home and virtual settings.' Only Ramsay's community-based psychology clinics are closing, not its hospital mental health services or inpatient and day programs. Federal Greens leader Larissa Waters said half of Australians who needed mental health support already could not get it. 'The waiting lists are huge, and so it's devastating to see that a private healthcare operator is going to close down yet more facilities, and where are those people going to go?' she said. 'Health care shouldn't be for profit, and it shouldn't be how much money you've got on your credit card to enable you to get the health care that you need. 'So it's a real shame that profit seems to be driving this outcome that will have a real impact.' Ramsay Health is listed on the Australian sharemarket and valued at $8.9bn. The company's share price is down 16 per cent over the past 12 months. In August, Ramsay Health Care reported a nearly triple full-year profit of $888.7m, up from $298.1m the year before. The large return was mostly due to the sale of Ramsay's stake in Ramsay Sime Darby, which owns hospitals in Malaysia and Indonesia. The financial results gave shareholders an 80 cent dividend per share across the financial year. 'The government should be providing healthcare services as a universal right of all Australians, and it shouldn't be whether or not a private company's profit margin is going to work to determine the outcomes for Australians' access to mental health care,' Ms Waters said. The 17 clinics are being shut progressively until the final one closes the doors permanently by the end of August. Four Melbourne clinics are being shut, three in Sydney will close, two in Perth will shut, and single clinics on the Sunshine Coast, Ipswich, the Gold Coast, NSW's Central Coast and Wollongong will close. 'After careful consideration, we are transitioning Ramsay Psychology to a more flexible and sustainable model, which includes the progressive closure of 17 clinics by the end of August,' the Ramsay spokesperson said. 'Three clinics, in Cairns (QLD), Charlestown (NSW) and Joondalup (WA), will remain open to support local needs, maintain key partnerships and pilot more integrated models of care. 'Ramsay Health Care is reshaping how it delivers community-based mental health support to better meet the evolving needs of clients and clinicians.' The National Mental Health Commission's National Report Card was also released on Thursday, the same day as news of the Ramsay closures broke. Health commission chief executive David McGrath said fewer and fewer people could afford mental health care. 'We have also seen a steady rise in financial stress and in the proportion of people in Australia delaying mental health care due to cost in the last four years,' Mr McGrath said in the report. 'Disappointingly, many social factors impacting mental health are not showing improvement (e.g. loneliness and experiences of discrimination) and positive experiences of mental health care have remained stable.' People were feeling less secluded than in the previous year, the commission found, and more people were getting help now than in 2007. 'However, there is no question there is a long way to go – our younger generations continue to report heightened psychological distress and financial stress and have a much higher prevalence of mental health challenges relative to the rest of the population,' Mr McGrath said.


Perth Now
10 hours ago
- Perth Now
‘Devastating': Private health giant shuts clinics
The country's biggest private hospital company will shut the majority of its psychology clinics in a matter of months. Ramsay Health Care notified staff of the closure of 17 of its 20 clinics earlier this month. The three remaining clinics are in the Newcastle suburb of Charlestown, in Perth's northern suburbs, and in Cairns. 'We understand this change might be unsettling and we are working closely with our psychologists to ensure every client is supported and has continuity of care, whether through our existing and expanded Telehealth service or with another trusted provider, depending on what is clinically appropriate,' a spokesperson said. 'This change is part of Ramsay's broader strategy to strengthen how we deliver high-quality, accessible and connected care across hospital, home and virtual settings.' Ramsay Health Care is a major player in Australia's private healthcare industry. Jason Edwards / NewsWire Credit: News Corp Australia Only Ramsay's community-based psychology clinics are closing, not its hospital mental health services or inpatient and day programs. Federal Greens leader Larissa Waters said half of Australians who needed mental health support already could not get it. 'The waiting lists are huge, and so it's devastating to see that a private healthcare operator is going to close down yet more facilities, and where are those people going to go?' she said. 'Health care shouldn't be for profit, and it shouldn't be how much money you've got on your credit card to enable you to get the health care that you need. 'So it's a real shame that profit seems to be driving this outcome that will have a real impact.' Ramsay Health is listed on the Australian sharemarket and valued at $8.9bn. The company's share price is down 16 per cent over the past 12 months. Erina on the NSW Central Coast is one of the clinics to close. Google Credit: Supplied In August, Ramsay Health Care reported a nearly triple full-year profit of $888.7m, up from $298.1m the year before. The large return was mostly due to the sale of Ramsay's stake in Ramsay Sime Darby, which owns hospitals in Malaysia and Indonesia. The financial results gave shareholders an 80 cent dividend per share across the financial year. 'The government should be providing healthcare services as a universal right of all Australians, and it shouldn't be whether or not a private company's profit margin is going to work to determine the outcomes for Australians' access to mental health care,' Ms Waters said. The 17 clinics are being shut progressively until the final one closes the doors permanently by the end of August. Ramsay Health Care's share price has tumbled over the past year. NewsWire / Gaye Gerard Credit: News Corp Australia Four Melbourne clinics are being shut, three in Sydney will close, two in Perth will shut, and single clinics on the Sunshine Coast, Ipswich, the Gold Coast, NSW's Central Coast and Wollongong will close. 'After careful consideration, we are transitioning Ramsay Psychology to a more flexible and sustainable model, which includes the progressive closure of 17 clinics by the end of August,' the Ramsay spokesperson said. 'Three clinics, in Cairns (QLD), Charlestown (NSW) and Joondalup (WA), will remain open to support local needs, maintain key partnerships and pilot more integrated models of care. 'Ramsay Health Care is reshaping how it delivers community-based mental health support to better meet the evolving needs of clients and clinicians.' The National Mental Health Commission's National Report Card was also released on Thursday, the same day as news of the Ramsay closures broke. Health commission chief executive David McGrath said fewer and fewer people could afford mental health care. 'We have also seen a steady rise in financial stress and in the proportion of people in Australia delaying mental health care due to cost in the last four years,' Mr McGrath said in the report. 'Disappointingly, many social factors impacting mental health are not showing improvement (e.g. loneliness and experiences of discrimination) and positive experiences of mental health care have remained stable.' People were feeling less secluded than in the previous year, the commission found, and more people were getting help now than in 2007. 'However, there is no question there is a long way to go – our younger generations continue to report heightened psychological distress and financial stress and have a much higher prevalence of mental health challenges relative to the rest of the population,' Mr McGrath said.